Rate My Professor Andrew Kruse

Andrew Kruse is Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He received B.S. degrees in Mathematics and Biochemistry from the University of Minnesota in 2009 and a Ph.D. in Structural Biology from Stanford University in 2014, where he completed doctoral training with Brian Kobilka studying neurotransmitter receptor structure, function, and pharmacology. Prior to joining the faculty at Harvard, Kruse focused his early research on these areas. His laboratory investigates the molecular basis of membrane protein signaling, with particular emphasis on G protein-coupled receptors and other transmembrane proteins involved in neurotransmission, cardiovascular function, metabolic homeostasis, and related physiological processes. The work employs techniques including protein engineering, structural biology, pharmacology, and combinatorial biology approaches to facilitate structural studies and develop protein ligands.

Kruse has received several recognitions for his contributions, including selection for the 2016 Forbes “30 under 30” list, the 2016 Vallee Scholar Award, a Smith Family Award for Excellence in Biomedical Research, a Klingenstein-Simons Fellowship, an NIH Director’s Early Independence Award, and the ASPET John J. Abel Award. His research aims to advance understanding of transmembrane signaling mechanisms to support the development of new therapeutics.